- Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study | May 12th TM SIG 8:30am PST/11:30am EST
- The use of telemedicine (TM) has accelerated in recent years, yet research on the implementation and effectiveness of TM-delivered medication treatment for opioid use disorder (MOUD) has been limited. In this presentation, Yih-Ing Hser, Ph.D., one of two Principal Investigators of the Greater Southern California Node of the National Institute on Drug Abuse Clinical Trials Network, will discuss the feasibility of implementing a care coordination model involving MOUD delivered via an external TM provider to expand access to MOUD for patients in rural settings. Join the Zoom meeting here.
- New publications:
- Hser YI, Mooney LJ, Baldwin LM, Ober A, Marsch LA, Sherman S, Matthews A, Clingan S, Fei Z, Zhu Y, Dopp A, Curtis ME, Osterhage KP, Hichborn EG, Lin C, Black M, Calhoun S, Holtzer CC, Nesin N, Bouchard D, Ledgerwood M, Gehring MA, Liu Y, Ha NA, Murphy SM, Hanano M, Saxon AJ. Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study. J Rural Health. 2023 Apr 19. doi: 10.1111/jrh.12760. PMID: 37074350. This paper is related to the CTN-0102-Phase One Feasibility Study
- Lin C, Pham H, Zhu Y, Clingan SE, Lin LA, Murphy SM, Campbell CI, Sorrell TR, Liu Y, Mooney LJ, Hser YI. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2023 Jan 1;242:109711. doi: 10.1016/j.drugalcdep.2022.109711. PMID: 36462230; PMCID: PMC9683518. The GSCN research team and the CTN Telemedicine SIG collaboratively prepared this paper
